Roxbury Financial LLC Makes New Investment in Oscar Health, Inc. $OSCR

Roxbury Financial LLC purchased a new stake in Oscar Health, Inc. (NYSE:OSCR) during the first quarter, according to the company in its most recent filing with the SEC. The firm purchased 18,602 shares of the company’s stock, valued at approximately $213,000.

Several other institutional investors also recently made changes to their positions in the stock. Quarry LP grew its stake in shares of Oscar Health by 439.8% during the 3rd quarter. Quarry LP now owns 1,803 shares of the company’s stock valued at $34,000 after buying an additional 1,469 shares during the period. Jones Financial Companies Lllp boosted its holdings in Oscar Health by 7,473.3% in the first quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock valued at $30,000 after acquiring an additional 2,242 shares during the last quarter. Strs Ohio purchased a new stake in Oscar Health during the first quarter valued at about $30,000. Fifth Third Bancorp increased its stake in Oscar Health by 148.7% during the fourth quarter. Fifth Third Bancorp now owns 2,363 shares of the company’s stock worth $34,000 after acquiring an additional 1,413 shares during the last quarter. Finally, Binnacle Investments Inc acquired a new stake in Oscar Health during the second quarter worth about $75,000. 75.70% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Oscar Health

In other Oscar Health news, insider Adam Mcananey sold 9,859 shares of the stock in a transaction that occurred on Tuesday, June 2nd. The shares were sold at an average price of $21.94, for a total value of $216,306.46. Following the completion of the sale, the insider owned 218,096 shares of the company’s stock, valued at $4,785,026.24. This trade represents a 4.32% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Janet Liang sold 12,475 shares of Oscar Health stock in a transaction that occurred on Tuesday, June 2nd. The shares were sold at an average price of $21.94, for a total transaction of $273,701.50. Following the sale, the insider owned 259,057 shares in the company, valued at $5,683,710.58. This represents a 4.59% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 189,660 shares of company stock worth $4,283,140 over the last 90 days. 25.11% of the stock is owned by corporate insiders.

Oscar Health Price Performance

Shares of NYSE OSCR opened at $28.52 on Tuesday. The company has a debt-to-equity ratio of 0.26, a current ratio of 1.11 and a quick ratio of 1.11. Oscar Health, Inc. has a 1-year low of $10.69 and a 1-year high of $29.81. The company has a market capitalization of $8.60 billion, a price-to-earnings ratio of -48.35, a PEG ratio of 1.99 and a beta of 2.37. The business has a 50-day moving average of $21.89 and a 200-day moving average of $17.02.

Oscar Health (NYSE:OSCR) last announced its earnings results on Wednesday, May 6th. The company reported $2.07 EPS for the quarter, beating the consensus estimate of $1.11 by $0.96. The business had revenue of $4.65 billion for the quarter, compared to the consensus estimate of $4.90 billion. Oscar Health had a negative return on equity of 3.26% and a negative net margin of 0.30%.The company’s revenue was up 52.6% on a year-over-year basis. During the same period last year, the business posted $0.92 EPS. On average, equities analysts anticipate that Oscar Health, Inc. will post 0.47 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on the company. Weiss Ratings raised Oscar Health from a “sell (d)” rating to a “sell (d+)” rating in a research note on Tuesday, June 9th. Wolfe Research began coverage on shares of Oscar Health in a report on Tuesday, May 5th. They issued a “peer perform” rating on the stock. UBS Group lifted their price target on shares of Oscar Health from $15.00 to $20.00 and gave the company a “neutral” rating in a research report on Thursday, May 7th. Jefferies Financial Group upgraded shares of Oscar Health from an “underperform” rating to a “hold” rating and boosted their price objective for the stock from $10.00 to $16.00 in a research note on Monday, April 20th. Finally, Wells Fargo & Company set a $20.00 target price on shares of Oscar Health and gave the company an “equal weight” rating in a research note on Thursday, June 4th. Three research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $20.78.

Oscar Health Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.